Margaret attended A&E at the hospital after falling in January 2019. A routine chest X-ray, part of the hospital's protocol for patients over 60 with this type of injury, showed a significant abnormality on her lungs, but the hospital never contacted Margaret about the scan.
In February 2020, Margaret underwent a CT scan for a separate issue that showed the abnormality on her left lung. Following further investigations, Lister Hospital diagnosed her with late stage, terminal cancer, 20-months after the chest X-ray.
By the time of her diagnosis, Margaret's cancer was too advanced for curative surgery and/or chemotherapy. Her only option was palliative immunotherapy which she began in December 2020.
Margaret instructed Jonathan to investigate a case on her behalf. With the support of expert evidence, Jonathan argued that Lister Hospital failed to follow-up on the chest X-ray, which meant that her lung cancer went undiagnosed for over 20 months and untreated for 23 months.
Lister Hospital accepted that there had been a failure to follow up on her chest X-ray and that with timely treatment, her cancer would have been cured. Settlement negotiations followed and Jonathan was able to achieve just over £520,000 for Margaret.
At the end of the case, Margaret said:
"Jonathan made what could have been a very difficult and stressful time, as painless as possible. I felt safe in his hands because he was so accessible, reassuring and kind. He knew what he was doing and provided practical help and support so that I did not feel that I was embarking on this litigation on my own. I really am very grateful. To have achieved the outcome which we did was a bonus!"
For further information about delayed diagnosis claims and medical negligence claims, please call Jonathan Zimmern on 03304606779 or email email@example.com.
- You can speak to our medical negligence lawyers on freephone 0800 358 3848
- e-Mail them at firstname.lastname@example.org
- Complete the short online enquiry form
All enquiries are completely free of charge and we will investigate all funding options for you including no win, no fee.
Sign up to our email digest